Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine as an Adjunct Therapy in Rheumatoid Arthritis
NCT04757571Phase 2Withdrawn
- Sponsor
- Sadat City University
- Start
- Feb 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paroxetine in rheumatoid arthritis (RA), sponsored by Sadat City University. Planned start Feb 2021; status: withdrawn.
02
Drugs
paroxetine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04757571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04757571.